Progress made in human genetics has revealed increasingly more disease-associated genes for Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. These discoveries have linked neurodegenerative diseases with several common key biological processes that now need further study. At the same time, tremendous strides have been made in microglial research, revealing unexpected results that challenge the traditional view of microglia as simply scavengers of the diseased CNS. The aims to conferences on "Advances in Neurodegenerative Disease Research and Therapy" and "New Frontiers in Neuroinflammation" were to:
To view the program of these conferences, visit www.keystonesymposia.org/18Z3 and www.keystonesymposia.org/18Z4.
This digital package for 100 USD, consists of:
The 100 USD access fee covers our administrative costs. Register to purchase the package; once you purchase, you will have unlimited access to log back into the website to view the content. If you have any questions, please contact our Attendee Services Department at email@example.com.
*Please note that any SciTalk / ePanel videos will be available for free 1 year after the publish date.
A screencast is a digital video recording that captures actions taking place on a computer display. The Keystone Symposia presenters recorded their presentations remotely and provided voice-over narration for their presentation materials.
Virtual Access is a Keystone Symposia initiative that is designed to provide access to digital content derived from a popular (often oversubscribed) Keystone Symposia conference. It leverages digital media to extend our face-to-face conferences' reach to the broader scientific community. The intent is to disseminate the latest research and fulfill our existing mandate of catalyzing the advancement of biomedical life sciences by convening high-quality scientific conferences.